TSS
IGC icon

Two Sigma Securities’s IGC Pharma IGC Stock Holding History

Two Sigma Securities’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,028
Closed -$14.6K – 1732
2025
Q3 		$14.6K Buy
35,028
+23,194
+196% +$8.82K ﹤0.01% 1177
2025
Q2 		$3.62K Buy
+11,834
New +$3.56K ﹤0.01% 1376
2025
Q1 		– Sell
-60,863
Closed -$20.4K – 1800
2024
Q4 		$20.4K Sell
60,863
-38,154
-39% -$14.3K ﹤0.01% 1314
2024
Q3 		$42.3K Buy
99,017
+65,412
+195% +$26.2K ﹤0.01% 2392
2024
Q2 		$14.6K Buy
33,605
+17,168
+104% +$8.54K ﹤0.01% 2759
2024
Q1 		$6.58K Buy
+16,437
New +$5.1K ﹤0.01% 2811
2023
Q4 		– Sell
-47,750
Closed -$17.2K – 3279
2023
Q3 		$17.2K Buy
47,750
+32,306
+209% +$11.6K ﹤0.01% 2597
2023
Q2 		$4.81K Buy
+15,444
New +$5K ﹤0.01% 2671
2023
Q1 		– Sell
-22,466
Closed -$7.15K – 2941
2022
Q4 		$7.15K Sell
22,466
-14,835
-40% -$6.05K ﹤0.01% 2413
2022
Q3 		$16K Buy
+37,301
New +$19.9K ﹤0.01% 2327
2022
Q2 		– Sell
-14,436
Closed -$14K – 2514
2022
Q1 		$14K Buy
+14,436
New +$14K ﹤0.01% 2020
2021
Q4 		– Sell
-19,866
Closed -$29K – 1772
2021
Q3 		$29K Sell
19,866
-12,362
-38% -$20K ﹤0.01% 1433
2021
Q2 		$53K Buy
+32,228
New +$49.2K ﹤0.01% 1394
2019
Q3 		– Sell
-13,874
Closed -$23K – 2235
2019
Q2 		$23K Sell
13,874
-661
-5% -$934 ﹤0.01% 1935
2019
Q1 		$30K Buy
+14,535
New +$33K ﹤0.01% 1646
2016
Q2 		– Sell
-13,848
Closed -$7K – 464
2016
Q1 		$7K Buy
+13,848
New +$4.19K 0.01% 272

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Two Sigma Securities's IGC Position: Q4 2025 in Review

Two Sigma Securities sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 35,028 shares — an estimated $14.6K sold.

Two Sigma Securities first reported a position in IGC in Q1 2016 and held it in 16 quarters. The position peaked at $53K in Q2 2021. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • Two Sigma Securities reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 35,028 IGC Pharma shares in Q4 2025, an estimated $14.6K.
  • Two Sigma Securities first reported a position in IGC Pharma in Q1 2016 and held it in 16 quarters.
  • Two Sigma Securities's IGC Pharma position peaked at $53K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.